Aurobindo Pharma Limited (AUROPHARMA) announces the launch of generic Advair Diskus® in the US market by its subsidiary Lannett Company LLC.
Aurionpro Solutions Ltd secures a USD 33 million engagement with a leading US fintech platform, expanding its AI-led technology solutions.